References
- Wood C D, Graybiel A. A theory of motion sickness based on pharmacological reaction. Clin Pharmacol Ther 1970; 11: 621–9
- Graybiel A, Wood C D, Knepton J, Perkins GF. Human assay of antimotion sickness drugs. Aviat Space Environ Med 1975; 46: 1107–18
- Takeda N, Inagaki S, Taguchi Y, Tohyama M, Watanabe T, Wada H. Origins of histamine containing fibers in the cerebral cortex of rats studied by immunohistochemistry with histidine decarboxylase as a marker and transection. Brain Res 1984; 323: 55–63
- Watanabe T, Taguchi Y, Shiosaka S, Tanaka J, Kubota H, Terano Y, Tohyama M, Wada H. Distribution of the histaminergic neuron system of rat: a fluorescent immunohistochemical analysis with histidine decarboxylase as a marker. Brain Research 1984; 295: 13–25
- Takeda N, Morita M, Watanabe T, Wada H, Tohyama M, Kubo T, Matsunaga T. Histaminergic projections from the posterior hypothalamus to the medial vestibular nucleus in rats. Sensory-motor Function under Weightlessness and Space Motion Sickness, Y Mitarai, M Igarashi. The University of Nagoya Press. 1985; 91–8
- Takeda N, Morita M, Kubo T, Yamatodani A, Watanabe T, Wada H, Tohyama M, Matsunaga T. Histaminergic projection from the posterior hypothalamus to the medial vestibular nucleus and its relation to motion sickness. Proceedings of Barany Society Meeting 1985, in press
- Tyler D B, Bard P. Motion sickness. Physiol Rev 1949; 29: 311–69
- Money KE. Motion sickness. Physiol Rev 1970; 50: 1–30
- Hatcher R A, Weiss S. Studies on vomiting. J Pharmacol Exp Ther 1923; 22: 139–93
- Mitchell D, Well C, Hoch N, Lind K, Woods S C, Mitchell LK. Poison induced pica in rats. Physiol Behav 1976; 17: 691–7
- Mitchell D, Laycock J D, Stephens WF. Motion-induced pica in rats. J Clin Nutr 1977; 30: 147–50
- Mitchell D, Krusemark M L, Hafner E. A species relevant assay of motion sickness in rat. Physiol Behav 1977; 18: 125–30
- Reason J T, Brand JJ. Motion Sickness. Academic Press, New York 1975
- Benson AJ. Motion sickness, MR Dix, JD Hood. Vertigo. John Wiley & Sons. 1984; 391–426
- Glowinski J, Iversen LL. Regional studies of catecholamines in the rat brain. I. J Neurochem 1966; 13: 655–99
- Yamatodani A, Fukuda H, Wada H, Iwaeda T, Watanabe T. HPLC determination of plasma and brain histamine without previous purification of biological samples. J Chromatogr Biomed Appl 1985; 344: 115–23
- Kollonitsch J, Patchett A, Marburg S, Maycock A L, Perkins LM. Biosynthesis of aminergic neurotransmitters. Nature (London) 1978; 274: 906–8
- Kubota H, Hayashi H, Watanabe T, Taguchi Y, Wada H. Mechanism of inactivation of mammalian L-histidine decarboxcylase by (S)-a-fluoromethylhistidine. Biochem Pharmacol 1984; 33: 983–90
- Garbarg M, Barbin G, Rodergas E, Schwartz JC. Inhibition of histamine synthesis in brain by a-fluoromethylhistidine, a new irreversible inhibitor: in vitro and in vivo studies. J Neurochem 1980; 35: 1045–52
- Maeyama K, Watanabe T, Taguchi Y, Yamatodani A, Wada H. The effect of α-fluoromethylhistidine, a suicide inhibitor of histidine decarboxylase, on histamine levels in mouse brain. Biochem Pharmacol 1982; 31: 2367–70
- Maeyama K, Watanabe T, Yamatodani A, Taguchi Y, Kambe H, Wada H. Effect of a-fluoromethylhistidine on the histamine content of the brain of W/W mice devoid of mast cells: Turnover of brain histamine. J Neurochem 1983; 41: 128–34
- Brown R D, Wood CD. Vestibular pharmacology. Trends Pharmacol Sci 1980; 1: 150–3